Schedule 13G ownership disclosure
REVOLUTION MEDICINES INC COM
Common Stock · CUSIP: 76155X100
Event date: 2026-09-30
- Filing-level shares
- 10,999,044
- Percent of class
- 5.13%
- Vanguard Capital Management
Shares: 10,999,044 · Class: 5.13%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002100119-26-001650
- Form type
- SCHEDULE 13G
- Filer
- VANGUARD CAPITAL MANAGEMENT LLC
- CIK
- CIK 2100119
- Filed
- Oct 30, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership